Ignite Creation Date:
2024-05-06 @ 8:40 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02798510
Status:
UNKNOWN
Last Update Posted:
2016-06-22
First Post:
2016-06-09
Brief Title:
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
Sponsor:
Fudan University
Organization:
Fudan University
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2016-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The present study is designed to determine whether adjuvant concurrent chemoradiotherapy improves overall survivals
Detailed Description:
The role of adjuvant radiotherapy in gallbladder carcinoma GBCA or extrahepatic cholangiocarcinoma EHCC is unknown A retrospective study suggested that chemoradiotherapy provides greater benefit than chemotherapy alone in GBCA patients SWOG S0809 a phase II study showed that adjuvant chemoradiotherapy has promising efficacy in GBCA or EHCC The present phase III clinical trial is designed to compare adjuvant concurrent chemoradiotherapy with chemotherapy alone
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None